cp 424391 has been researched along with ulimorelin in 1 studies
| Studies (cp 424391) | Trials (cp 424391) | Recent Studies (post-2010) (cp 424391) | Studies (ulimorelin) | Trials (ulimorelin) | Recent Studies (post-2010) (ulimorelin) |
|---|---|---|---|---|---|
| 34 | 7 | 20 | 23 | 10 | 15 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baell, J; Ban, K; Brock, JA; Callaghan, B; Ferens, D; Furness, JB; Kosari, S; Nguyen, TV; Pustovit, RV; Rivera, LR; Sartor, DM | 1 |
1 other study(ies) available for cp 424391 and ulimorelin
| Article | Year |
|---|---|
Hypotensive effects of ghrelin receptor agonists mediated through a novel receptor.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Ghrelin; HEK293 Cells; Humans; Hypotension; In Vitro Techniques; Macrocyclic Compounds; Male; Mesenteric Arteries; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Ghrelin | 2014 |